Normetanephrine is a breakdown product of norepinephrine, one of the body’s main stress hormones. When your doctor orders a plasma or urine normetanephrine test, the primary concern is usually a rare but serious type of tumor called a pheochromocytoma or paraganglioma, both of which pump out excess stress hormones and drive up normetanephrine levels. Elevated normetanephrine does not automatically mean you have a tumor, though, because medications, testing conditions, and even your age can push the numbers above the reference range.
How Normetanephrine Is Produced
Your adrenal glands and certain nerve endings release norepinephrine as part of the fight-or-flight response. Once norepinephrine has done its job, the body needs to deactivate it. One of the main enzymes responsible is called COMT, which converts norepinephrine into normetanephrine. A second enzyme, MAO, breaks norepinephrine down through a separate pathway. These two routes work in parallel. If you block one, the other picks up the slack: blocking COMT causes normetanephrine to drop (because the conversion stops), while blocking MAO causes normetanephrine to rise (because it is no longer being broken down after its formation).1PubMed. Different metabolism of norepinephrine and epinephrine by catechol-O-methyltransferase and monoamine oxidase in rats This biochemical relationship matters clinically, because several common psychiatric medications work by blocking MAO or blocking norepinephrine reuptake, and both can push normetanephrine levels high enough to trigger a false alarm on testing.
Normetanephrine circulates in two forms: a “free” form and a sulfate-conjugated form. The conjugated form is created by an enzyme concentrated in the gut, which means food can influence conjugated levels. The free form is not affected by what you eat, and it does not require an extra chemical processing step in the lab, which gives it higher specificity for detecting tumors.2Endocrinology and Metabolism. Urinary Free Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma Most modern guidelines favor measuring free normetanephrine in plasma or urine rather than the older total or conjugated assays.
Why Doctors Order This Test
The main reason for a normetanephrine test is to screen for pheochromocytomas and paragangliomas, collectively called PPGLs. These are catecholamine-secreting tumors. Pheochromocytomas grow in the adrenal gland, while paragangliomas arise in nerve tissue outside the adrenals. They are uncommon, found in roughly one in a thousand people with high blood pressure and about four percent of people with an incidentally discovered adrenal mass on imaging.3PubMed Central. Pheochromocytomas and secreting paragangliomas Despite their rarity, missing the diagnosis can be dangerous because the uncontrolled hormone surges can cause hypertensive crises, heart attacks, and strokes.
Older screening approaches relied on measuring catecholamines directly or on breakdown products like vanillylmandelic acid. Those tests are now considered less reliable as initial screens. Plasma free metanephrines (which include both normetanephrine and metanephrine) almost always reveal a PPGL when one is present, making them the preferred first-line test.4PubMed. New advances in the biochemical diagnosis of pheochromocytoma: moving beyond catecholamines You will usually see both normetanephrine and metanephrine reported together, because the pattern of which is elevated tells the doctor something about the type and location of a potential tumor.
What Selectively Elevated Normetanephrine Can Reveal
When normetanephrine alone is high while metanephrine stays normal, the tumor is almost certainly making norepinephrine rather than epinephrine. This pattern is called a noradrenergic biochemical phenotype, and it shows up in specific clinical scenarios. Patients with von Hippel-Lindau disease, a genetic condition that predisposes to various tumors, have been found to have almost exclusively elevated normetanephrine, whereas patients with multiple endocrine neoplasia type 2 tend to show high metanephrine.5PubMed. Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2 This distinction is useful because it steers genetic testing and helps predict where the tumor is likely to be.
Paragangliomas of the urinary bladder offer another example. In one series of bladder paraganglioma patients, about ninety percent had a noradrenergic phenotype, and roughly half carried a mutation in the SDHB gene.6PubMed Central. Association of urinary bladder paragangliomas with germline mutations in the SDHB and VHL genes SDHB mutations are important to identify because they raise the risk of malignant disease and metastasis, and they call for lifelong surveillance.
Case reports illustrate just how dramatically normetanephrine can rise when a tumor is active. A 21-year-old woman with a recurrent pheochromocytoma had plasma normetanephrine over seven times the upper limit of normal and urine normetanephrine roughly three and a half times the upper limit.7Journal of the Endocrine Society. SAT-494 Small but Mighty: A case of Normetanephrine-Predominant Pheochromocytoma with High Catecholamine Activity Another case involved a 21-year-old man whose plasma normetanephrine was more than seventeen times the upper limit.8Journal of the Endocrine Society. 6891 Exclusive Normetanephrine Secreting Pheochromocytoma In A Young Male These wildly elevated numbers make diagnosis straightforward; the diagnostic challenge arises when the elevation is only mild to moderate.
Medications That Raise Normetanephrine Without a Tumor
Some of the most commonly prescribed psychiatric medications can elevate normetanephrine enough to mimic a tumor. Tricyclic antidepressants and serotonin-norepinephrine reuptake inhibitors both block norepinephrine reuptake, which keeps more norepinephrine circulating and leads to increased production of normetanephrine. In one large study, patients on tricyclics or SNRIs had plasma normetanephrine levels roughly 35 to 42 percent higher than patients without a tumor, and their rate of false-positive test results was nearly five times that of untreated patients.9PubMed Central. False-positive results for pheochromocytoma associated with norepinephrine reuptake blockade SSRIs, which primarily target serotonin rather than norepinephrine, did not significantly raise normetanephrine in the same study.
Beyond antidepressants, other substances and conditions can create a pseudo-pheochromocytoma picture with paroxysmal high blood pressure, palpitations, and sweating in the absence of any tumor. Obstructive sleep apnea, physiologic stress, antipsychotic and anti-Parkinson drugs, and stimulant drugs like cocaine have all been associated with this presentation.10Bioscientifica (Endocrinology, Diabetes and Metabolism Case Reports). Pseudo-pheochromocytoma due to obstructive sleep apnea: a case report If your normetanephrine is mildly elevated, your doctor will want to know every medication and supplement you take before ordering further workup.
How Body Position During Blood Draw Affects Results
This is one of the more surprising details about normetanephrine testing: whether you sit upright or lie down for the blood draw meaningfully changes the numbers. When blood is drawn from seated patients without a rest period beforehand, the upper reference limits for plasma metanephrines are higher than when patients lie down for 20 to 30 minutes first. A study comparing the two positions found that using seated reference limits on samples from patients who actually had a pheochromocytoma decreased diagnostic sensitivity from 99 percent to 96 percent. And among patients without a tumor, using seated cutoffs to interpret results while preserving that 99 percent sensitivity inflated false-positive rates from 9 percent to 25 percent.11PubMed. Is supine rest necessary before blood sampling for plasma metanephrines?
In practical terms, the best approach is to have blood drawn after lying quietly for at least 20 minutes. Many clinics skip this step for convenience, but the trade-off is a much higher chance of a false positive that leads to unnecessary imaging and anxiety. If you receive a borderline result from a seated draw, repeating the test under supine conditions can clarify things considerably.
Age and Sex Differences in Normal Ranges
Normetanephrine is not static across a lifespan. Plasma normetanephrine rises steadily with age, and the upper reference limit more than doubles from childhood to over age 60.12PubMed Central. Reference intervals for plasma free metanephrines with an age adjustment for normetanephrine for optimized laboratory testing of phaeochromocytoma This matters because using a single cutoff for everyone means that older adults are much more likely to receive false-positive results. The gain in diagnostic accuracy from using age-adjusted reference ranges largely comes from reclassifying older patients’ results from false positive to true negative.
Sex also plays a role, though the effect depends on which specimen you test. Plasma metanephrine tends to be higher in males than in females after correcting for age and body size, while urinary normetanephrine-to-creatinine ratios tend to be higher in females, likely because women generally have less muscle mass and therefore excrete less creatinine.13PubMed. Reference intervals for LC-MS/MS measurements of plasma free, urinary free and urinary acid-hydrolyzed deconjugated normetanephrine, metanephrine and methoxytyramine Age turns out to be the most important adjustment for plasma normetanephrine, whereas sex is more practical for interpreting urinary metabolites. Urinary normetanephrine excretion also increases with age in both sexes, with separate reference ranges recommended for people under 30, between 30 and 40, and over 40.14PubMed. Reference intervals for deconjugated urine metanephrines by Bhattacharya analysis If your lab report uses a single adult reference range with no age or sex stratification, a mildly abnormal result in an older patient deserves more skepticism than it might otherwise receive.
What Happens After an Elevated Result
A single elevated normetanephrine result does not seal a diagnosis. The first step is usually to review medications, confirm proper collection conditions, and often repeat the test. If the elevation persists after accounting for confounders, the next move depends on how high the value is. Very high levels, say three or four times the upper limit or more, carry a high probability of a real tumor and typically lead directly to imaging. Mildly elevated results are trickier, because a substantial fraction of them turn out to be false positives.
For borderline elevations, the clonidine suppression test can help. Clonidine lowers norepinephrine release from normal nerve endings but does not affect autonomous secretion from a tumor. In patients with elevated baseline normetanephrine, one study found the test correctly identified all patients who did not have a PPGL, achieving 100 percent specificity.15PubMed. Clonidine suppression test for a reliable diagnosis of pheochromocytoma: When to use The test has also been useful in patients with neurofibromatosis type 1, a genetic condition with higher than usual rates of pheochromocytoma, where baseline false-positive results are a frequent problem.16PubMed Central. Clonidine suppression testing for pheochromocytoma in neurofibromatosis type 1
Imaging After Biochemical Confirmation
Once the biochemistry convincingly points toward a tumor, the next question is where it is. Pheochromocytomas sit in or near the adrenal glands and are usually visible on CT or MRI of the abdomen. Paragangliomas can pop up almost anywhere along the sympathetic nerve chain, from the skull base to the pelvis, which sometimes requires specialized functional imaging to locate.
A prospective comparison of six different imaging approaches for sporadic pheochromocytoma found that 18F-FDOPA PET/CT and MRI each detected all tumors tested, while standard CT picked up only about two-thirds.17PubMed Central. Sporadic Primary Pheochromocytoma: A Prospective Intraindividual Comparison of Six Imaging Tests For metastatic disease involving bone, 68Ga-DOTATATE PET/CT has shown strong detection, identifying nearly all spinal bone metastases at the per-lesion level, outperforming FDG PET, MRI, and whole-body CT.18PubMed Central. Diagnostic performance of [68Ga]DOTATATE PET/CT, [18F]FDG PET/CT, MRI of the spine, and whole-body diagnostic CT and MRI in the detection of spinal bone metastases associated with pheochromocytoma and paraganglioma The choice of imaging depends on the clinical scenario: a straightforward adrenal mass usually needs only a CT or MRI, while suspected extra-adrenal or metastatic disease calls for functional scans.
Normetanephrine Testing in Children
In pediatric patients, elevated normetanephrine raises a different diagnostic possibility: neuroblastoma. This is a childhood cancer that arises from the same type of nerve tissue as pheochromocytomas but behaves very differently. Neuroblastoma is most common in children under five and is one of the most frequent solid tumors in infants.
Plasma free normetanephrine and a related metabolite called 3-methoxytyramine both show strong diagnostic accuracy for neuroblastoma. In one study, normetanephrine achieved 80 percent sensitivity and nearly 96 percent specificity for distinguishing neuroblastoma patients from healthy controls, and there was a positive correlation between normetanephrine levels measured in urine and plasma.19PubMed. Plasma free metanephrines for diagnosis of neuroblastoma patients A separate analysis confirmed that normetanephrine was among the most commonly elevated catecholamine metabolites in neuroblastoma regardless of how urine was collected or which lab method was used.20Pediatric Blood & Cancer. Optimising urinary catecholamine metabolite diagnostics for neuroblastoma For parents who encounter normetanephrine on their child’s lab report, it is worth knowing that the test is used in pediatric oncology as well as endocrinology, and the reference ranges for children differ substantially from adult values.
Preparing for Surgery When a Tumor Is Found
If a pheochromocytoma or paraganglioma is confirmed and surgical removal is planned, preoperative preparation with blood-pressure-lowering medication is essential. The tumor can release massive amounts of norepinephrine during handling, and without adequate blockade, this surge can cause a life-threatening hypertensive crisis on the operating table.
The standard approach is to start an alpha-blocker at least one to two weeks before surgery. Phenoxybenzamine, a long-acting non-selective alpha-blocker, has been the traditional choice, but doxazosin, a shorter-acting selective blocker, is increasingly used. A randomized trial comparing the two found no clinically meaningful difference in how much time patients spent outside blood-pressure targets during surgery, and the 30-day cardiovascular complication rates were similar at roughly 7 to 9 percent in both groups.21The Journal of Clinical Endocrinology & Metabolism. Efficacy of α-Blockers on Hemodynamic Control during Pheochromocytoma Resection: A Randomized Controlled Trial The practical takeaway for patients is that either drug can adequately prepare you for surgery, and the choice often comes down to availability, side-effect profile, and your surgeon’s preference.
Genetic Testing and Familial Syndromes
A surprising fraction of PPGLs are hereditary. Current estimates suggest that around 30 to 40 percent of pheochromocytomas and paragangliomas are linked to a germline mutation, making genetic testing a routine recommendation for anyone diagnosed with one of these tumors. The list of implicated genes has grown steadily and now includes VHL, the RET proto-oncogene, the succinate dehydrogenase subunit genes (SDHA, SDHB, SDHC, SDHD, SDHAF2), and several others.
From the normetanephrine perspective, the biochemical phenotype of a tumor can actually hint at the genetic cause. Tumors associated with VHL mutations tend to produce normetanephrine almost exclusively, with very little metanephrine, because they lack the enzyme that converts norepinephrine to epinephrine.5PubMed. Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2 SDHB-mutated tumors similarly show a predominantly noradrenergic phenotype and sometimes also secrete dopamine metabolites.6PubMed Central. Association of urinary bladder paragangliomas with germline mutations in the SDHB and VHL genes When a lab report shows normetanephrine elevated in isolation, the genetic evaluation often starts with VHL and SDH gene panels. Identifying a mutation has cascading implications: it determines surveillance schedules, prompts screening of family members, and sometimes changes the surgical approach.
Living With Mildly Elevated Normetanephrine
Not every elevated normetanephrine test leads to a dramatic diagnosis. A significant number of people end up in a gray zone where levels are above the reference range but not alarmingly high, imaging shows no tumor, and the clonidine suppression test is reassuring. In these situations, the elevation often reflects medications, sympathetic nervous system hyperactivity from conditions like obstructive sleep apnea, chronic stress, or simply the natural age-related rise in baseline normetanephrine. For older adults, the mismatch between their biology and the lab’s reference range is a common source of unnecessary worry.
If you find yourself in this category, the most productive steps are to work with your doctor to exclude medication effects, to ensure any underlying sleep apnea or chronic stress is addressed, and to establish a monitoring schedule. Periodic retesting, perhaps annually, lets your doctor track whether levels are stable or climbing. A stable mildly elevated normetanephrine in someone over 50 who is on an SNRI and has treated sleep apnea tells a very different story from the same number in a 25-year-old with episodic hypertension and no clear explanation. Context matters far more than the number itself.